ArticleDermatology and therapy2026

Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial.

Melinda Gooderham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.